Optical Q™ Fluorescence Immunoassay Analyzer

Detect SARS-CoV-2 nAbswithin 15 minutes

Monitor and evaluate vaccine efficacy and immunity Yield 99.5% accuracy with our fluorescence immunoassay analyzer Scalable solution with results within 15 minutes Batch multiple samples and yield 3,000 tests per day in 1 device Does not require any expensive lab equipment Easy and simple 3 steps : dilute, drop, analyze

The Optical Q™ SARS CoV-2 Neutralization Antibody Test

Accurately measure your level of immunity

Neutralizing Antibodies(Nabs)

SARS-CoV-2 vaccines provide active acquired immunity against SARS-CoV-2 by inciting growth of neutralizing antibodies (nAbs) ‒s pecial antibodies designed to prevent SARS Cov-2 from binding to the ACE2 receptor of human cells.

High levels of nAbs indicate immunity against COVID-19.

Clinical Applications

Immunization monitoring Detection of SARS-CoV-2 nAbs in serum of recovering COVID-19 patients	Vaccine Evaluation Detection of SARS-CoV-2 nAbs in serum of Vaccinated patients

Why Optical Q™ nAb?

	Vaccines do not guarantee immunity – they works differently on every individual Accurate measurements of nAbs in recovering patients and/or vaccinated patients are crucial not only to evaluate vaccine efficacy, but also to assure which patients have developed immunity.
	Very few solutions Standard igm/igg antibody tests ‒ which are universally available ‒ do not detect for nAbs and can only provide an indirect indication for immunity. Optical Q™ SARS CoV-2 nAb is one few tests that can detect and quantitatively measure nAbs.
	Available solutions are expensive in all aspects Solutions that do provide accurate nAb tests are expensive, time-consuming, and are not scalable. Optical Q™ SARS CoV-2 nAb test is 4x quicker, 1/3rd the cost of the next best solution, and does not require lab equipment for scalability.

The Optical Q™ SARS CoV-2 Neutralization Antibody Test

The most accurate rapid test kit for nAbs

How it works

Specifications(Optical Q™ CoV-19 nAb)